Table 1.
Characteristics of ASCT patients.
| Variable | All ASCT | COVID-19– | COVID-19+ |
|---|---|---|---|
| Total patients, n (%) | 442 | 422 (95.5) | 20 (0.45) |
| Sex | |||
| Male | 278 (62.9) | 267 (63.3) | 11 (55) |
| Female | 164 (37.1) | 155 (36.7) | 9 (45) |
| Age (range 18.3–74.2 years) | |||
| 18–19 | 1 (0.2) | 1 (0.2) | 0 |
| 20–29 | 4 (0.9) | 4 (0.9) | 0 |
| 30–39 | 12 (2.7) | 12 (2.8) | 0 |
| 40–49 | 38 (8.6) | 33 (7.8) | 5 (25) |
| 50–59 | 131 (29.6) | 127 (30.1) | 4 (20) |
| 60–69 | 219 (49.5) | 209 (51.9) | 10 (50) |
| 70- | 37 (8.4) | 36 (8.5) | 1 (5) |
| Median, years | 61.4 | 61.6 | 60.2 |
| Hematological disease | |||
| Myeloma | 301 (68.1) | 288 (68.2) | 13 (65) |
| Other plasma cell disease | 17 (3.8) | 16 (3.8) | 1 (5) |
| B-cell lymphoma | 94 (21.3) | 90 (21.3) | 4 (20) |
| Hodgkin lymphoma | 13 (2.9) | 12 (2.8) | 1 (5) |
| T-cell lymphoma | 17 (3.8) | 16 (3.8) | 1 (5) |
| Transplantation center | |||
| Karolinska | 94 (21.2) | 89 (21.1) | 5 (25) |
| Linköping | 45 (10.2) | 41 (9.7) | 4 (20) |
| Sahlgrenska | 91 (20.6) | 88 (20.9) | 3 (15) |
| Skåne | 74 (16.7) | 71 (16.8) | 3 (15) |
| Uppsala | 66 (14.9) | 62 (14.7) | 4 (20) |
| Umeå | 37 (8.4) | 36 (8.5) | 1 (5) |
| Örebro | 35 (7.9) | 35 (8.3) | 0 |
ASCT: autologous hematopoietic stem cell transplantation.
The table shows the characteristics of all patients treated with hematopoietic autologous stem cell transplantation for hematological malignancy in Sweden in 2020 and how many of those later tested positive for SARS-CoV-2.